Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 51, Issue , 2014, Pages 65-71

  Hashemizadeh, Shiva ^a   Sardari, Maryam ^a   Rezayof, Ameneh ^a,b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

Basolateral amygdala; CB1 cannabinoid receptors; Nicotine; Rat(s); Reward

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; NICOTINE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BENZOXAZINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NICOTINIC AGENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADULT; ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BRAIN FUNCTION; BRAIN REGION; CONDITIONED PLACE PREFERENCE TEST; CONDITIONING; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REWARD; SCORING SYSTEM; AGONISTS; AMYGDALOID NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; METABOLISM; MICROINJECTION; MOTOR ACTIVITY; WISTAR RAT;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; BENZOXAZINES; CALCIUM CHANNEL BLOCKERS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROINJECTIONS; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; NICOTINE; NICOTINIC AGONISTS; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 84893379345     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.01.010     Document Type: Article

References (67)

1. Alijanpour S., Rezayof A. Involvement of dorsal hippocampal and medial septal nicotinic receptors in cross state-dependent memory between WIN55, 212-2 and nicotine or ethanol in mice. Neuroscience 2013, 245:61-73.
2. Ambroggi F., Ishikawa A., Fields H.L., Nicola S.M. Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons. Neuron 2008, 59:648-661.
3. Biala G., Kruk M., Budzynska B. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. J Physiol Pharmacol 2009, 60:113-122.
4. Brielmaier J.M., McDonald C.G., Smith R.F. Nicotine place preference in a biased conditioned place preference design. Pharmacol Biochem Behav 2008, 89:94-100.
5. Budzyńska B., Kruk M., Biała G. Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacol Rep 2009, 61:304-310.
6. Carr G.D., White N.M. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci 1983, 33:2551-2557.
7. Castañé A., Valjent E., Ledent C., Parmentier M., Maldonado R., Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 2002, 43:857-867.
8. Changeux J.P. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci 2010, 11:389-401.
9. Chaperon F., Soubrié P., Puech A.J., Thiébot M.H. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl) 1998, 135:324-332.
10. Cheer J.F., Kendall D.A., Marsden C.A. Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology (Berl) 2000, 151:25-30.
11. Cheer J.F., Wassum K.M., Sombers L.A., Heien M.L., Ariansen J.L., Aragona B.J., et al. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 2007, 27:791-795.
12. Cohen C., Perrault G., Voltz C., Steinberg R., Soubrié P. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 2002, 13:451-463.
13. Corrigall W.A., Franklin K.B., Coen K.M., Clarke P.B. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 1992, 107:285-289.
14. Cunningham C.L., Noble D. Methamphetamine-induced conditioned place preference or aversion depending on dose and presence of drug. Ann N Y Acad Sci 1992, 654:431-433.
15. Cunningham C.L., Okorn D.M., Howard C.E. Interstimulus interval determines whether ethanol produces conditioned place preference or aversion in mice. Anim Learn Behav 1997, 25:31-42.
16. Di Ciano P., Everitt B.J. Direct interactions between the basolateral amygdala and nucleus accumbens core underlie cocaine-seeking behavior by rats. J Neurosci 2004, 24:7167-7173.
17. Fang Q., Li F.Q., Li Y.Q., Xue Y.X., He Y.Y., Liu J.F., et al. Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats. Pharmacol Biochem Behav 2011, 99:738-742.
18. Floresco S.B., Blaha C.D., Yang C.R., Phillips A.G. Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons. J Neurosci 2001, 21:6370-6376.
19. Forget B., Hamon M., Thiébot M.H. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 2005, 181:722-734.
20. Fudala P.J., Teoh K.W., Iwamoto E.T. Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol Biochem Behav 1985, 22:237-241.
21. Goniewicz M.L., Delijewski M. Nicotine vaccines to treat tobacco dependence. Hum Vaccin Immunother 2013, 9:13-25.
22. González S., Cascio M.G., Fernández-Ruiz J., Fezza F., Di Marzo V., Ramos J.A. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 2002, 954:73-81.
23. Gotti C., Guiducci S., Tedesco V., Corbioli S., Zanetti L., Moretti M., et al. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 2010, 30:5311-5325.
24. Heinrichs S.C., Leite-Morris K.A., Guy M.D., Goldberg L.R., Young A.J., Kaplan G.B. Dendritic structural plasticity in the basolateral amygdala after fear conditioning and its extinction in mice. Behav Brain Res 2013, 248:80-84.
25. Hendrickson L.M., Guildford M.J., Tapper A.R. Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. Front Psychiatry 2013, 4:29.
26. Ignatowska-Jankowska B.M., Muldoon P.P., Lichtman A.H., Damaj M.I. The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice. Psychopharmacology (Berl) 2013, 229:591-601.
27. Jackson K.J., Kota D.H., Martin B.R., Damaj M.I. The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology 2009, 56:970-974.
28. Jorenby D.E., Steinpreis R.E., Sherman J.E., Baker T.B. Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology (Berl) 1990, 101:533-538.
29. Kenny P.J., Markou A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 2006, 3:1203-1211.
30. Kodas E., Cohen C., Louis C., Griebel G. Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling. Psychopharmacology (Berl) 2007, 194:161-171.
31. Laviolette S.R., Grace A.A. Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs. J Neurosci 2006, 26:6458-6468.
32. Le Foll B., Goldberg S.R. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 2004, 15:2139-2143.
33. Le Foll B., Goldberg S.R. Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology (Berl) 2005, 178:481-492.
34. Litvin Y., Phan A., Hill M.N., Pfaff D.W., McEwen B.S. CB1 receptor signaling regulates social anxiety and memory. Genes Brain Behav 2013, 12:479-489.
35. López-Moreno J.A., González-Cuevas G., Moreno G., Navarro M. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. Addict Biol 2008, 13:160-187.
36. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 2005, 168:299-325.
37. Mansvelder H.D., Keath J.R., McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 2002, 33:905-919.
38. Manzanedo C., Aguilar M.A., Rodríguez-Arias M., Navarro M., Miñarro J. Cannabinoid agonist-induced sensitisation to morphine place preference in mice. Neuroreport 2004, 15:1373-1377.
39. Mark G.P., Shabani S., Dobbs L.K., Hansen S.T. Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 2011, 104:76-81.
40. McDonald A.J., Mascagni F. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 2001, 107:641-652.
41. 1 receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. Behav Brain Res 2013, 237:333-337.
42. Pak A.C., Ashby C.R., Heidbreder C.A., Pilla M., Gilbert J., Xi Z.X., et al. The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 2006, 9:585-602.
43. Pastor V., Andrés M.E., Bernabeu R.O. The effect of previous exposure to nicotine on nicotine place preference. Psychopharmacology (Berl) 2013, 226:551-560.
44. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, San Diego.
45. Perra S., Pillolla G., Luchicchi A., Pistis M. Alcohol inhibits spontaneous activity of basolateral amygdale projection neurons in the rat: involvement of the endocannabinoid system. Alcohol Clin Exp Res 2008, 32:443-449.
46. Pessoa L. Emotion and cognition and the amygdala: from "what is it?" to "what's to be done?". Neuropsychologia 2010, 48:3416-3429.
47. Phillips A.G., Ahn S., Howland J.G. Amygdalar control of the mesocorticolimbic dopamine system: parallel pathways to motivated behavior. Neurosci Biobehav Rev 2003, 27:543-554.
48. Pidoplichko V.I., Noguchi J., Areola O.O., Liang Y., Peterson J., Zhang T., et al. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn Mem 2004, 11:60-69.
49. Polissidis A., Chouliara O., Galanopoulos A., Marselos M., Papadopoulou-Daifoti Z., Antoniou K. Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure. Life Sci 2009, 85:248-254.
50. Rezayof A., Sardari M., Zarrindast M.R., Nayer-Nouri T. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behav Brain Res 2011, 220:1-8.
51. Rezayof A., Ghandipour M., Nazari-Serenjeh F. Effect of co-injection of arachydonilcyclopropylamide and ethanol on conditioned place preference in rats. Physiol Behav 2012, 107:301-308.
52. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83:803-834.
53. Sañudo-Peña M.C., Tsou K., Delay E.R., Hohman A.G., Force M., Walker J.M. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 1997, 223:125-128.
54. Shim J.Y., Ahn K.H., Kendall D.A. Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi. J Biol Chem 2013, 288:32449-32465.
55. Stuber G.D., Sparta D.R., Stamatakis A.M., van Leeuwen W.A., Hardjoprajitno J.E., Cho S., et al. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature 2011, 475:377-380.
56. Sugase-Miyamoto Y., Richmond B.J. Neuronal signals in the monkey basolateral amygdala during reward schedules. J Neurosci 2005, 25:11071-11083.
57. Sun N., Laviolette S.R. Inactivation of the basolateral amygdala during opiate reward learning disinhibits prelimbic cortical neurons and modulates associative memory extinction. Psychopharmacology (Berl) 2012, 222:645-661.
58. Tan H., Bishop S.F., Lauzon N.M., Sun N., Laviolette S.R. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects. Neuropharmacology 2009, 56:741-751.
59. Valjent E., Mitchell J.M., Besson M.J., Caboche J., Maldonado R. Behavioural and biochemical evidence for interactions between delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 2002, 135:564-578.
60. Vlachou S., Panagis G. Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals. Curr Pharm Des 2014, 20:1-17.
61. Walters C.L., Brown S., Changeux J.P., Martin B., Damaj M.I. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 2006, 184:339-344.
62. Wassum K.M., Tolosa V.M., Tseng T.C., Balleine B.W., Monbouquette H.G., Maidment N.T. Transient extracellular glutamate events in the basolateral amygdala track reward-seeking actions. J Neurosci 2012, 32:2734-2746.
63. Yararbas G., Keser A., Kanit L., Pogun S. Nicotine-induced conditioned place preference in rats: sex differences and the role of mGluR5 receptors. Neuropharmacology 2010, 58:374-382.
64. Yin R., French E.D. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study. Brain Res Bull 2000, 51:507-514.
65. Zarrindast M.R., Fattahi Z., Rostami P., Rezayof A. Role of the cholinergic system in the rat basolateral amygdala on morphine-induced conditioned place preference. Pharmacol Biochem Behav 2005, 82:1-10.
66. Zarrindast M.R., Nouri M., Ahmadi S. Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP. Brain Res 2007, 13:130-137.
67. Zhu P.J., Stewart R.R., McIntosh J.M., Weight F.F. Activation of nicotinic acetylcholine receptors increases the frequency of spontaneous GABAergic IPSCs in rat basolateral amygdala neurons. J Neurophysiol 2005, 94:3081-3091.